Thuja Capital is an independent venture capital firm specialized in investing in early-stage medical product companies in the Benelux. We are currently actively investing out of Thuja Capital Healthcare Fund II. We focus on early-stage private companies that aim to develop and commercialize innovative medical products, for cure, care or prevention. We will consider any product proposition, irrespective of the regulatory class or technological basis, e.g. medical technology, medical devices, diagnostics, health monitoring technologies, therapeutics, medical food products, supplements, cross-over and borderline products. We look for propositions which still require (clinical) validation in order to enable marketing with a health claim. Companies that merely need growth capital we will not consider. We will only consider products that convincingly contribute to a sustainable healthcare, i.e. products that improve quality and that enable cost-effective healthcare.